USA A1 Trading Advice (B) | 11-Sep-2024 | Expected Gain 6%-7%

 BUY   Exelixis (NASDAQ: EXEL)

Exelixis (NASDAQ: EXEL) STOCK RECOMMENDATION

Idea BUY
Buy Range 25.75 – 26.25
Target 27.75 – 28
StopLoss* below 25
Duration 12-14 Trading Days
Potential Returns 6% – 7%
Idea Buy Range Target StopLoss* Duration Potential Returns
BUY 25.75 – 26.25 27.75 – 28 below 25 12-14 Trading Days 6% – 7%

* Once the first target hit, reset the StopLoss at your buying price.

Our recommendations are authentic and transparent. Find this recommendation posted in Tradingview. Be assured such records are permanent and irreversible.

Exelixis (NASDAQ: EXEL) STOCK OVERVIEW

Exelixis, Inc. is an oncology company focused on finding and marketing new treatments for difficult cancers in the U.S. It offers CABOMETYX tablets for advanced renal cell carcinoma patients who have had prior anti-angiogenic therapy, and COMETRIQ capsules for progressive metastatic medullary thyroid cancer. Both drugs are based on cabozantinib, which blocks various tyrosine kinases like MET, AXL, RET, and VEGF receptors. The company also provides COTELLIC, a MEK inhibitor for some advanced melanoma cases, and MINNEBRO, an oral hypertension blocker in Japan. Exelixis is working on zanzalintinib, a next-gen oral tyrosine kinase inhibitor targeting VEGF and MET, as well as XB002, an ADC targeting tissue factor. It has partnerships with several pharmaceutical firms and a clinical agreement with Sairopa B.V. for ADU-1805. Founded in 1994 and originally named Exelixis Pharmaceuticals, Inc., it rebranded to Exelixis, Inc. in February 2000 and is based in Alameda, California.

Stock Data
NASDAQ Symbol EXEL
Sectoral Index Health Care
52 Weeks High 27.53
52 Weeks Low 18.64

Exelixis (NASDAQ: EXEL) - RELATIVE STRENGTH

EXEL-RELATIVE STRENGTH

Relative Performance - Last 1 Year

Exelixis —     NASDAQ —

Exelixis (NASDAQ: EXEL) - DAILY TECHNICAL ANALYSIS

Exelixis (NASDAQ: EXEL) - Technical Analysis (Daily)
  • Following the breakdown of the Rising Wedge pattern, the price entered an extended consolidation phase.
  • During this time, a Rounding Bottom pattern emerged on the chart.
  • Once the price broke above the neckline of the Rounding Bottom, it experienced a upward movement but faced resistance near the 27.5 level.
  • After a short pullback, the stock price is currently on an upward trend, with expectations that it may exceed the immediate resistance and sustain its position above that level.

Exelixis (NASDAQ: EXEL) - RSI

Exelixis (NASDAQ: EXEL) - RSI
  • Current RSI of this stock is 61.60, which indicates the strength of buyers.

Exelixis (NASDAQ: EXEL) - EMA CROSS

EXEL-EMA CROSS
Exelixis (NASDAQ: EXEL) - EMA Cross
  • The short length exponential moving average (10 EMA) has crossed the long length exponential moving average (20 EMA) from the below, generates bullish signal. Last dayโ€™s candle has closed above all these moving averages. This suggests buyers are taking interest in this stock.

Exelixis (NASDAQ: EXEL) - ADX & DI

EXEL-ADX & DI
Exelixis (NASDAQ: EXEL) - ADX & DI
  • Increasing ADX value above 20, indicated the strength of the trend, thereby uptrending ADX confirms the bullish or bearish supportive decisions. Along with the rising ADX, and the +DI is above (or crossing) -DI, indicates the long trades should be favoured.

CONCLUSION - Exelixis (NASDAQ: EXEL) STOCK PRICE FORECAST

Based on our stock trading advice in USA, Exelixis stock price target will be USD 27.75 – USD 28 in the next 12-14 trading sessions.

Exelixis (NASDAQ: EXEL) TRADINGVIEW POSITION UPDATE

MONEY MANAGEMENT AND TRADING RULES

1)ย  Itโ€™s advisable to enter/exit in the recommended range.
2)ย  Strictly follow the StopLoss as mentioned. Honour it.
3) ย Use trailing StopLoss to retain profits.
4)ย  Diversify trading capital into our other trading recommendations.
5)ย  Risk only the money what you can afford to lose. Hedge accordingly.

Advisor / ANALYST SUMMARY

The stock trading advice is prepared by the Naranj Capital team under the guidance ofย Arijit Banerjee, CMT, CFTe. Arijit is a veteran trader and an active investor having in-depth knowledge of financial market research, advanced technical analysis, market cycle, algorithmic trading, and portfolio management. He is a Chartered Market Technician (CMT) accredited by CMT Association USA, the global authority of Technical Analysis and also has been honored as aย Certified Financial Technician (CFTe)ย by the International Federation of Technical Analysts, USA.

Disclosure

The views expressed herein are based solely on information available publicly/internal data/other sources believed to be reliable, but is not necessarily all-inclusive and is not guaranteed as to accuracy. The recommendations provided herein is solely for informational purposes and are not intended to be and must not be taken alone as the basis for an investment/trading decision. Trading and investing are subject to market risk and the securities discussed and opinions expressed herein may not be suitable for all investors. To read the full disclosure, please click here.

Enjoy this recommendation?
Share with your friends

Your return could be more

PROFITABLE!

access our premium recommendations

๐Ÿ‡บ๐Ÿ‡ธ  A1 Trading Advice

USA Stock Markets NYSE & NASDAQ

Navigate the market like a pro with expert trading signals at your fingertips. Unlock valuable insights and stay ahead of the game.

Pricing

Pricing (in USD)

Email Newsletter

Get Free Saudi Stock Trading Advice

We respect your privacy.

For Any Queries, Call or Whatsapp +91-8335058282

You cannot copy content of this page

× Chat With Us